UnitedHealth stock dropped 33% amid fraud concerns, CEO resignation, and suspended 2025 guidance. Read why UNH continues to ...

Discover why Artisan Partners Asset Management Inc. is poised to outperform. Click for my review of APAM's latest earnings ...

Under Armour faces declining revenue, weak DTC and footwear sales, and tariff uncertainties, complicating its turnaround ...

Large-cap growth led in 2023 and 2024, thanks to the two years of +25% returns for the SP 500, but the value style held in ...

Hello, ladies and gentlemen, and welcome to the Carl Zeiss Meditec AG Analyst Conference for the Six Months 2025 Results. At this time, all participants have been placed on a listen-only mode. The ...

Gold futures posted their worst weekly showing in nearly four years, as the U.S.-China tariff de-escalation removed some ...

Schwab U.S. Dividend Equity remains a conservative, diversified choice for stable, reliable, and growing dividends. Click for ...

Bayer A.G.'s stock is undervalued but faces risks with declining profits & regulatory pressures. Click for my updated look at ...

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

With the premium down 10% from the high, I am willing to give GOF a cautious buy rating again. Read to know why GOF may be a ...

Strathcona's hostile bid for MEG Energy undervalues the company. We go over the mechanics behind the deal and tell you why ...

Explore Leonardo S.p.a.'s 100% stock surge amid Europe's defense focus. Click for my updated look at FINMY stock post Q1 ...